Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (33700)
All Articles published online
|
Publishing Process of This Article
|
Jan 30, 2019 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Pharmacology
ISSN
2220-3192
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2022 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 94 | 33.2% |
| 2 | China | 28 | 9.9% |
| 3 | Netherlands | 19 | 6.7% |
| 4 | Sweden | 16 | 5.7% |
| 5 | Australia | 13 | 4.6% |
| 6 | Canada | 12 | 4.2% |
| 7 | Russia | 12 | 4.2% |
| 8 | United Kingdom | 11 | 3.9% |
| 9 | Germany | 8 | 2.8% |
| 10 | Singapore | 8 | 2.8% |
| 11 | India | 8 | 2.8% |
| 12 | Korea, Republic of | 5 | 1.8% |
| 13 | Nigeria | 5 | 1.8% |
| 14 | Chile | 4 | 1.4% |
| 15 | Hong Kong | 4 | 1.4% |
| 16 | Austria | 3 | 1.1% |
| 17 | Philippines | 3 | 1.1% |
| 18 | Spain | 2 | 0.7% |
| 19 | Pakistan | 2 | 0.7% |
| 20 | Saudi Arabia | 2 | 0.7% |
| 21 | Bangladesh | 2 | 0.7% |
| 22 | Malawi | 2 | 0.7% |
| 23 | Malaysia | 1 | 0.4% |
| 24 | Mauritius | 1 | 0.4% |
| 25 | Iraq | 1 | 0.4% |
| 26 | Ireland | 1 | 0.4% |
| 27 | Italy | 1 | 0.4% |
| 28 | Japan | 1 | 0.4% |
| 29 | Belgium | 1 | 0.4% |
| 30 | Brazil | 1 | 0.4% |
| 31 | Czech Republic | 1 | 0.4% |
| 32 | Egypt | 1 | 0.4% |
| 33 | Senegal | 1 | 0.4% |
| 34 | Serbia | 1 | 0.4% |
| 35 | Greece | 1 | 0.4% |
| 36 | Grenada | 1 | 0.4% |
| 37 | Poland | 1 | 0.4% |
| 38 | Taiwan | 1 | 0.4% |
| 39 | Tanzania, United Republic of | 1 | 0.4% |
| 40 | Thailand | 1 | 0.4% |
| 41 | Ukraine | 1 | 0.4% |
| 42 | Viet Nam | 1 | 0.4% |